Recombinant Daucus carota Unknown protein 1

What molecular characteristics define the Dau c 1 protein family in Daucus carota?

The Dau c 1 protein family in carrots comprises multiple isoallergens and variants with varying degrees of sequence identity. According to current research, at least four established isoallergens exist: Dau c 1.01, 1.02, 1.03, and 1.04, with Dau c 1.01 further comprising five variants (Dau c 1.0101 to Dau c 1.0105). Recent mass spectrometry studies have revealed several previously unknown Dau c 1-like proteins, including newly characterized isoallergens Dau c 1.0501 and Dau c 1.0601 .

How are novel proteins initially discovered in Daucus carota extracts?

The discovery of novel proteins in Daucus carota involves a multi-stage process combining advanced analytical techniques with bioinformatic approaches:

• Isolation of natural protein fractions from carrot root tissue

• Analysis using liquid chromatography-mass spectrometry elevated energy (LC-MSᴱ) to generate peptide profiles

• Database searching of identified peptides against existing repositories for Daucus carota and related species

• Genome mining using BLAST to locate complete gene sequences corresponding to peptide fragments

• Primer design targeting 3' and 5' UTR regions based on the Daucus carota genome for cDNA amplification

• Sequence verification and comparison to known protein families

This systematic approach has led to the discovery of several novel Dau c 1-related sequences that were subsequently expressed in E. coli for further characterization. For example, researchers identified four database entries (A0A164WTA1, A0A175YPA2, D9ZHP1, and D9ZHP0) corresponding to potential new Dau c 1-like proteins .

What criteria determine whether a newly discovered carrot protein qualifies as an isoallergen?

Classification of a novel carrot protein as an isoallergen involves multiple criteria based on both sequence characteristics and immunological properties:

The identification process must be thorough as some proteins may show similar sequence characteristics but differ in allergenicity. For example, the study found that Dau c 1-like protein possesses 50-55% sequence identity to known isoallergens but exhibits no allergenicity, highlighting the importance of comprehensive immunological testing .

What expression systems are most effective for producing recombinant Daucus carota unknown proteins?

The choice of expression system for recombinant Daucus carota proteins depends on research objectives and protein characteristics:

For optimal expression of novel carrot proteins, researchers should consider:

• Vector selection: Choosing expression vectors with appropriate fusion tags (His-tag, GST, etc.) to enhance solubility and facilitate purification

• E. coli strain optimization: Testing multiple strains optimized for protein folding (e.g., Origami, Rosetta)

• Culture conditions: Manipulating temperature, induction timing, and inducer concentration

• Alternative systems: For proteins proving difficult in E. coli, eukaryotic systems like yeast or insect cells may preserve post-translational modifications and proper folding

When evaluating expression system success, assess both yield and quality metrics including SDS-PAGE for purity, size exclusion chromatography for oligomerization status, and functional assays for biological activity .

What mass spectrometry approaches best identify unknown proteins from Daucus carota?

Mass spectrometry plays a crucial role in identifying unknown carrot proteins, with liquid chromatography-mass spectrometry elevated energy (LC-MSᴱ) emerging as a particularly effective approach . This technique provides several advantages for characterizing complex protein mixtures from plant sources:

• Sample preparation:

  • Extraction of proteins from carrot tissue using buffer systems optimized for plant materials

  • Purification of target protein fractions through chromatographic techniques

  • Enzymatic digestion (typically with trypsin) to generate peptide fragments

• LC-MSᴱ analysis workflow:

  • Peptide separation via liquid chromatography

  • Alternating low and elevated collision energy scans to generate both precursor and fragment ion data

  • High mass accuracy measurements for confident peptide identification

• Data analysis strategy:

  • Search against databases containing Daucus carota sequences

  • Cross-referencing with related species (Pimpinella brachycarpa, Apium graveolens, Petrosilium crispum)

  • BLAST analysis of identified peptides against the carrot genome

This approach successfully revealed that natural Dau c 1 composition is more complex than previously thought, allowing identification of four database entries (A0A164WTA1, A0A175YPA2, D9ZHP1, and D9ZHP0) and several additional gene sequences through genome searching .

What methodological approaches provide definitive assessment of allergenicity for novel carrot proteins?

Comprehensive allergenicity assessment of novel carrot proteins requires multiple complementary methodologies that evaluate different aspects of allergen-IgE interactions:

• Immunoblotting assays:

  • Proteins separated by SDS-PAGE under non-reducing conditions

  • Transfer to membranes followed by probing with sera from carrot-allergic patients

  • Detection of bound IgE using enzyme-conjugated anti-human IgE antibodies

  • Limitation: May destroy conformational epitopes during the blotting procedure

• ELISA inhibition assays:

  • Microtiter plates coated with reference allergen (e.g., 2 μg Dau c 1.0104 per well)

  • Serial dilutions of test protein followed by addition of patient serum

  • Quantification using HRP-labeled anti-human IgE and TMB substrate

  • Advantage: Maintains proteins in solution, better preserving conformational epitopes

• Mediator release assays:

  • Functional testing using effector cells (basophils or mast cells)

  • Measurement of mediator release upon allergen-IgE cross-linking

  • Provides information on biological activity beyond IgE binding

  • Required for WHO/IUIS Allergen Nomenclature acceptance

• Patient sera diversity:

  • Testing with sera from multiple patients with confirmed carrot allergy

  • Inclusion of patients with varying clinical symptom severity

  • Critical for capturing the highly individual nature of IgE repertoires

The integration of these methods provides a comprehensive allergenicity profile, as demonstrated in recent research where some proteins showed differential IgE binding depending on the assay format. For example, Dau c 1.0401 exhibited IgE-binding when soluble but showed impaired binding when immobilized on a membrane .

How can comparative structural analysis between allergenic and non-allergenic carrot proteins reveal functional IgE epitopes?

Comparative structural analysis between allergenic and non-allergenic carrot proteins offers powerful insights into IgE epitopes that determine allergenicity. Recent research identified a non-allergenic Dau c 1-like protein with 50-55% sequence identity to allergenic Dau c 1 isoallergens, providing an ideal comparative model .

The methodological approach involves:

• Sequence alignment analysis:

  • Multiple sequence alignment of allergenic and non-allergenic proteins

  • Identification of conserved regions versus variable regions

  • Mapping of amino acid substitutions that correlate with allergenicity

• Structural modeling workflow:

  • Generation of 3D models using Phyre2 computational platform

  • Visualization and analysis using PyMOL Molecular Graphics System

  • Superposition of allergenic and non-allergenic structures

  • Identification of surface-exposed regions that differ between proteins

• Epitope prediction algorithms:

  • Analysis of surface properties (hydrophobicity, charge distribution)

  • Identification of regions with high solvent accessibility

  • Correlation of structural features with experimental IgE binding data

What experimental strategies effectively map epitopes on recombinant Dau c 1 isoallergens?

Epitope mapping of recombinant Dau c 1 isoallergens requires a multi-faceted approach combining computational prediction with experimental validation:

• Sequence-based epitope prediction:

  • Alignment of allergenic isoallergens with non-allergenic Dau c 1-like protein

  • Identification of residues unique to allergenic variants

  • Computational prediction of surface-exposed regions

• Structure-guided fragment analysis:

  • Design of overlapping peptide fragments spanning regions of interest

  • Expression of recombinant protein fragments

  • IgE binding assessment of individual fragments using patient sera

  • Correlation of binding patterns with structural features

• Site-directed mutagenesis approach:

  • Targeted mutation of specific amino acids in predicted epitope regions

  • Expression of mutant proteins in E. coli

  • Comparative immunological analysis of wild-type versus mutant proteins

  • Quantification of changes in IgE binding capacity

• Conformational epitope analysis:

  • Comparison of IgE binding under native versus denaturing conditions

  • Mapping of conformational changes using circular dichroism spectroscopy

  • Correlation with immunological data from different assay formats

The importance of this approach is highlighted by the observation that during blotting procedures, proteins become partially denatured, resulting in altered IgE binding properties for certain isoallergens . This suggests that conformational epitopes play a critical role in allergenicity, requiring methods that preserve native protein structure during analysis.

How do expression conditions affect structural integrity and immunological properties of recombinant carrot proteins?

Expression conditions significantly impact the structural integrity and immunological properties of recombinant carrot proteins through multiple mechanisms:

• Protein folding dynamics:

  • Temperature effects: Lower induction temperatures (16-25°C) often improve folding of complex proteins

  • Induction rate: Slower expression using reduced inducer concentrations can enhance proper folding

  • Co-expression with chaperones: May facilitate correct folding of challenging proteins

• Solubility determinants:

  • Fusion partners: Solubility-enhancing tags can prevent aggregation during expression

  • Buffer composition: Optimization of pH, salt concentration, and additives during purification

  • Recent research showed one protein (Dau-Var2) proved completely insoluble despite optimization attempts

• Conformational stability impacts:

  • Purification methods: Harsh conditions may disrupt structural epitopes

  • Storage conditions: Temperature, pH, and buffer components affect long-term stability

  • Freeze-thaw cycles: Can induce partial denaturation affecting epitope integrity

• Immunological property correlation:

  • Soluble vs. immobilized formats: Some proteins show differential IgE binding depending on presentation

  • Native vs. denatured states: During blotting procedures, proteins become partially denatured, affecting IgE binding

  • Biological activity preservation: Properly folded proteins maintain functional epitopes

The complex relationship between expression conditions and functional properties is exemplified by Dau c 1.0401, which exhibits IgE-binding when in solution but shows impaired binding when immobilized on a membrane . This highlights the critical importance of optimizing expression and handling conditions to maintain structural integrity for accurate immunological characterization.

How should researchers reconcile conflicting immunological data obtained from different assay formats?

Reconciling conflicting immunological data from different assay formats requires systematic analysis and understanding of the technical limitations of each method:

• Assay format considerations:

  • Solution-phase assays (ELISA inhibition) vs. solid-phase assays (immunoblot)

  • Native conditions vs. partially denaturing conditions

  • Quantitative measurements vs. qualitative detection

  • The research demonstrates that during blotting procedures, proteins become partially denatured, potentially destroying conformational epitopes

• Protocol for conflicting data resolution:

  • Evaluate protein conformation in each assay format

  • Consider epitope accessibility differences between methods

  • Assess assay sensitivity and detection limits

  • Verify results using multiple complementary methods

• Case study analysis:

  • Dau c 1.0401 exhibited IgE-binding when soluble but showed impaired binding when immobilized on membranes

  • This suggests predominance of conformational epitopes disrupted during membrane attachment

  • Similar patterns may explain other apparently conflicting results

• Interpretation framework:

  • Prioritize functional assays (mediator release) for clinical relevance assessment

  • Use binding assays (ELISA, immunoblot) for epitope characterization

  • Consider patient-specific variability in IgE recognition patterns

  • Integrate data from multiple patients to establish meaningful patterns

The research emphasizes that "the IgE repertoire of patients allergic to carrots is highly individual" , further complicating data interpretation. This individual variability necessitates testing with multiple patient sera and careful consideration of apparent discrepancies between assay formats.

What bioinformatic tools and algorithms provide the most robust analysis for novel carrot protein characterization?

Comprehensive characterization of novel carrot proteins requires a strategic application of bioinformatic tools addressing sequence analysis, structural prediction, and functional annotation:

When characterizing novel proteins, an integrated bioinformatic workflow should:

• Begin with thorough sequence analysis to determine relationships to known proteins

• Calculate sequence identities to determine classification as isoallergens (>67% identity) or variants (>90% identity)

• Use structural prediction to identify potential epitopes and functional domains

• Search genomic data to identify related genes and potential gene families

• Validate bioinformatic predictions with experimental data

The application of these tools has successfully identified and characterized novel Dau c 1 isoallergens in recent research .

How do individualized IgE binding patterns to different carrot proteins inform personalized diagnosis and treatment approaches?

Individual IgE binding patterns to different carrot proteins provide critical insights that can inform personalized approaches to diagnosis and treatment:

• Patient-specific IgE recognition profiles:

  • Research demonstrates highly individualized binding patterns across patient sera

  • For example, Dau c 1.0501 reacted weakly with sera #14 and #44

  • Dau c 1.0601 reacted with five sera (#14, #31, #38, #40, #44), with strong reaction only for #44

  • Dau c 1-like showed different binding patterns with yet another set of patient sera

• Diagnostic implications:

  • Component-resolved diagnosis using multiple recombinant allergens provides more precise profiles

  • Identification of specific isoallergen sensitivity patterns

  • Correlation with cross-reactivity to related allergens (e.g., Bet v 1 from birch pollen)

  • Enhanced specificity compared to extract-based testing

• Severity correlation analysis:

  • Potential relationships between recognition of specific isoallergens and symptom severity

  • Identification of high-risk epitopes associated with more severe reactions

  • Development of risk stratification models based on molecular sensitization patterns

• Therapeutic strategy development:

  • Design of personalized immunotherapy formulations targeting specific isoallergens

  • Potential for hypoallergenic variants based on epitope modification

  • Development of targeted blocking antibodies against dominant epitopes

  • Research suggests that "identification of new isoallergens and the identification of IgE epitopes may contribute to personalized targeted treatment approaches"

• Monitoring protocol establishment:

  • Longitudinal tracking of sensitization patterns over time

  • Assessment of treatment efficacy based on changes in component-specific IgE

  • Early detection of emerging sensitizations to additional isoallergens

The complex landscape of individual IgE recognition profiles supports the move toward precision medicine approaches in allergy management, with component-resolved diagnosis using recombinant allergens providing the foundation for personalized treatment strategies .